{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:20:06Z","timestamp":1790439606570,"version":"4.1.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0057838","type":"journal-article","created":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T08:12:57Z","timestamp":1362211977000},"page":"e57838","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":126,"title":["Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials"],"prefix":"10.1371","volume":"8","author":[{"given":"Bipulendu","family":"Jena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourindra","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Huls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Champlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence J. N.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood-2007-12-128843","article-title":"Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells","volume":"112","author":"BG Till","year":"2008","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.1882","article-title":"Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma","volume":"14","author":"MA Pule","year":"2008","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/PPO.0b013e3181eb3879","article-title":"Adoptive cell therapy: genetic modification to redirect effector cell specificity","volume":"16","author":"RA Morgan","year":"2010","journal-title":"Cancer J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood-2010-04-281931","article-title":"Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19","volume":"116","author":"JN Kochenderfer","year":"2010","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"M Kalos","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2011-04-348540","article-title":"Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias","volume":"118","author":"RJ Brentjens","year":"2011","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells","volume":"119","author":"JN Kochenderfer","year":"2012","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"O\u2019Connor CM, Sheppard S, Hartline CA, Huls H, Johnson M, <etal>et al<\/etal>.. (2012) Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy. Scientific Reports 2. DOI: 10.1038\/srep00249.","DOI":"10.1038\/srep00249"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-5890(97)00144-2","article-title":"Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma","volume":"34","author":"IC Nicholson","year":"1997","journal-title":"Mol Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2011-12-398719","article-title":"Good T cells for bad B cells","volume":"119","author":"LJN Cooper","year":"2012","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nri2635","article-title":"Engineering lymphocyte subsets: tools, trials and tribulations","volume":"9","author":"CH June","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"RA Morgan","year":"2006","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1158\/0008-5472.CAN-07-5600","article-title":"Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system","volume":"68","author":"H Singh","year":"2008","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/hum.2009.114","article-title":"piggyBac transposon\/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies","volume":"21","author":"PV Manuri","year":"2009","journal-title":"Hum Gene Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/mt.2010.2","article-title":"A transposon and transposase system for human application","volume":"18","author":"PB Hackett","year":"2010","journal-title":"Mol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1158\/0008-5472.CAN-10-3843","article-title":"Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies","volume":"71","author":"H Singh","year":"2011","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1182\/blood-2012-01-405365","article-title":"A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR","volume":"119","author":"H Torikai","year":"2012","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Huls MH, Figliola MJ, Dawson MJ, Olivares S, Kebriaei P, <etal>et al<\/etal>.. (2012) Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood. J Vis Exp doi:10.3791\/50070.","DOI":"10.3791\/50070"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/protein\/6.8.989","article-title":"An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability","volume":"6","author":"M Whitlow","year":"1993","journal-title":"Protein Engineering"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia","volume":"365","author":"DL Porter","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/pros.20073","article-title":"Anti-prostate specific membrane antigen designer T cells for prostate cancer therapy","volume":"61","author":"Q Ma","year":"2004","journal-title":"Prostate"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1182\/blood-2004-12-4906","article-title":"Adoptive transfer of gene-engineered CD4+ helper T cells induces potent primary and secondary tumor rejection","volume":"106","author":"M Moeller","year":"2005","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1172\/JCI46110","article-title":"CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients","volume":"121","author":"B Savoldo","year":"2011","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"10995","DOI":"10.1158\/0008-5472.CAN-06-0160","article-title":"CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells","volume":"66","author":"CM Kowolik","year":"2006","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.mt.6300104","article-title":"Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma","volume":"15","author":"JR Park","year":"2007","journal-title":"Mol Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1182\/blood-2010-07-294520","article-title":"Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells","volume":"117","author":"CH Lamers","year":"2011","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/gt.2010.91","article-title":"Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc \u2018spacer\u2019 domain in the extracellular moiety of chimeric antigen receptors avoids \u2018off-target\u2019 activation and unintended initiation of an innate immune response","volume":"17","author":"A Hombach","year":"2010","journal-title":"Gene Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1182\/blood-2010-01-043737","article-title":"Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor","volume":"116","author":"B Jena","year":"2010","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ijc.1457","article-title":"Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes","volume":"94","author":"C Rossig","year":"2001","journal-title":"Int J Cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1182\/blood.V99.6.2009","article-title":"Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy","volume":"99","author":"C Rossig","year":"2002","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood-2006-04-017061","article-title":"T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells","volume":"108","author":"J Vera","year":"2006","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2002-07-1989","article-title":"T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect","volume":"101","author":"LJ Cooper","year":"2003","journal-title":"Blood"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0057838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:27:57Z","timestamp":1540337277000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0057838"}},"subtitle":[],"editor":[{"given":"Mitchell","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0057838","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,1]]}}}